Significant Ownership of NOVARTIS PHARMA AG

Signature - Title
/s/ Christian Rehm - Christian Rehm / Authorised Signatory
Location
Basel, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by NOVARTIS PHARMA AG.

Notify me when NOVARTIS PHARMA AG files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of NOVARTIS PHARMA AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ERAS Erasca, Inc. Common stock, par value $0.0001 per share 4.4% $14,892,307 12,307,692 Novartis Pharma AG 31 Dec 2024
DTIL PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share 3.7% $2,121,671 413,581 0% Novartis Pharma AG 30 Jun 2025

Schedules 13D/G Reported by NOVARTIS PHARMA AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.